Lv3
268 积分 2025-07-05 加入
Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement
23天前
已完结
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy
28天前
已关闭
α-Toxin of Staphylococcus aureus overcomes acquired cisplatin-resistance in malignant mesothelioma cells
1个月前
已完结
Translational Analysis of NSD3 Gene Amplification in Lung Squamous Cell Carcinoma: Clinical and Prognostic Insights From Histopathologic Analysis of Patient Samples
1个月前
已完结
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
2个月前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
2个月前
已完结
Malignant Pleural Effusion: Presentation, Diagnosis, and Management
2个月前
已完结
Challenges, opportunities, and therapeutic potential of JAK inhibitors and their derived PROTACs (2022 – 2023)
2个月前
已完结
Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy
3个月前
已完结
The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
3个月前
已完结
皖公网安备34019202002308
